世界卫生组织潜伏性结核筛查指南在低结核发病率地区的预估影响:回顾性队列研究
结果仅1.5%符合WHO强推荐风险因素,2814例活动性结核中118例(4.2%)被视为可通过筛查预防;扩大筛查范围后不足半数(49.4%)可预防。结论:在低发病率地区应用WHO强推荐对结核发病率影响有限,需识别更多高危人群。
要点
- 2814例活动性结核中仅118例(4.2%)可通过WHO风险因素筛查预防。
- 扩大筛查至高负担国家移民、免疫抑制药、糖尿病或癌症者,可预防比例升至49.4%。
核心结论
- 在低结核发病率移民人群中,应用WHO潜伏性结核筛查强推荐对结核发病率影响有限。
- 需进一步识别高危人群以制定低发病率地区有效的潜伏性结核筛查与治疗策略。
研究设计与样本
- 链接多个行政数据库识别符合WHO筛查强推荐风险因素者,并将风险因素诊断后≥6个月诊断的活动性结核定义为可预防。
主要发现
- 2814例活动性结核中118例(4.2%)被视为可通过WHO风险因素筛查预防。
- 扩大筛查至高结核负担国家移民、使用免疫抑制药物、糖尿病或癌症者后,可预防比例不足半数(49.4%)。
关键数值与推荐
- WHO强推荐筛查风险因素包括:结核接触、HIV感染、透析、使用TNF-α抑制剂、器官/血液移植或硅肺。
- 可预防活动性结核定义为风险因素诊断后≥6个月诊断的结核。
临床怎么用
- 在低发病率地区不宜仅依赖WHO强推荐风险因素开展潜伏性结核筛查。
- 应结合本地移民来源与合并症特征,识别更多高危人群以提升筛查效果。
局限性
- 为回顾性队列,依赖行政数据库识别风险因素与结核诊断。
- 可预防定义基于风险因素诊断后≥6个月的时间窗,可能受诊断时序影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Latent tuberculosis infection (LTBI) screening and treatment is a key component of the World Health Organization (WHO) EndTB Strategy, but the impact of LTBI screening and treatment at a population level is unclear. We aimed to estimate the impact of LTBI screening and treatment in a population of migrants to British Columbia (BC), Canada. METHODS: This retrospective cohort included all individuals (N = 1 080 908) who immigrated to Canada as permanent residents between 1985 and 2012 and were residents in BC at any time up to 2013. Multiple administrative databases were linked to identify people with risk factors who met the WHO strong recommendations for screening: people with tuberculosis (TB) contact, with human immunodeficiency virus, on dialysis, with tumor necrosis factor-alpha inhibitors, who had an organ/haematological transplant, or with silicosis. Additional TB risk factors included immunosuppressive medications, cancer, diabetes, and migration from a country with a high TB burden. We defined active TB as preventable if diagnosed ≥6 months after a risk factor diagnosis. We estimated the number of preventable TB cases, given optimal LTBI screening and treatment, based on these risk factors. RESULTS: There were 16 085 people (1.5%) identified with WHO strong risk factors. Of the 2814 people with active TB, 118 (4.2%) were considered preventable through screening with WHO risk factors. Less than half (49.4%) were considered preventable with expanded screening to include people migrating from countries with high TB burdens, people who had been prescribed immunosuppressive medications, or people with diabetes or cancer. CONCLUSIONS: The application of WHO LTBI strong recommendations for screening would have minimally impacted the TB incidence in this population. Further high-risk groups must be identified to develop an effective LTBI screening and treatment strategy for low-incidence regions.
引用
- Ronald LA, Campbell JR, Rose C, et al. Estimated Impact of World Health Organization Latent Tuberculosis Screening Guidelines in a Region With a Low Tuberculosis Incidence: Retrospective Cohort Study. Clin Infect Dis. 2019. PMID: 30856258. doi:10.1093/cid/ciz188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。